Quick Read - Invesco RAFI Emerging Markets ETF (PXH) — sustainable 3.5% yield from real company dividends, not return of capital. - PXH’s dividend is fully funded by underlying companies but varies quarterly due to seasonal payout timing across markets. - Currency fluctuations...
Quick Read - Amazon (AMZN) delivered Q1 results with AWS growing 28% year over year (fastest in 15 quarters), a chips business at $20 billion annual run rate, and EPS of $2.78 beating estimates by 61%, yet shares remain at $264.14 despite fundamentals suggesting higher...
Quick Read - Between 2001 and 2024, the cost of maintaining a basic standard of living rose 106% while wages stagnated, forcing millennials to reconsider traditional wealth-building rules that no longer align with economic realities. - Rather than aggressively paying down all...<
U.S. stock futures edge lower amid escalating geopolitical risks and rising Treasury yields, extending Friday’s sell-off. U.S. stock futures traded modestly lower early Monday, signaling a potential extension of Friday’s sharp losses. Investor sentiment remained under pres
Avantor’s lower-than-expected guidance triggered a 10.35% one-month decline, underperforming broader markets amid sector volatility. Avantor (AVTR) shares fell to $7.62 on May 15, 2026, after issuing guidance that disappointed investors. The stock posted a one-month return
Memory chip maker Kioxia reports record revenue and profit for fiscal 2024, citing surging AI-driven demand ahead of a potential U.S. listing. Kioxia announced plans to list American depositary shares in the U.S., citing strong demand for memory chips from AI data center b
Berkshire Hathaway sold its entire 5 million-share position in UnitedHealth, triggering a premarket decline in the insurer’s stock. UnitedHealth Group (UNH) shares fell over 3% in premarket trading after Berkshire Hathaway disclosed it exited its entire stake in the health
Key Points - KETAFREE moved closer to a potential summer 2026 approval after the FDA issued mostly minor review comments, and NRx said it has already begun commercial manufacturing at scale. Management believes the product could serve both hospital and ketamine clinic mark
Key Points - Niu’s Q1 2026 revenue and volume surged, with total sales volume rising about 29% year over year to roughly 261,000 units and revenue increasing 33.4% to RMB 909.5 million. Growth was driven mainly by a strong performance in China. - China demand was boosted b
Key Points - Membership revenue improved sequentially to CNY 4.2 billion in Q1, helped by hit dramas such as “The Punishment 2” and “Pursuit of Jade,” even as total revenue fell 8% sequentially to CNY 6.2 billion. Management said it will focus on reactivating dormant users
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.